Explaining racial and ethnic differences in antidepressant use among adolescents

Medical Care Research and Review

Volumn 67, Issue 3, 2010, Pages 342-363

  Kirby, James B ^a   Hudson, Julie ^a   Miller, G Edward ^a  

^a AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

Author keywords

Adolescents; Antidepressant; Race and ethnicity

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; DEPRESSION; DRUG COST; EDUCATION; ETHNIC DIFFERENCE; FAMILY ASSESSMENT; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH INSURANCE; HEALTH STATUS; HISPANIC; HUMAN; INCOME; MENTAL HEALTH; PRESCRIPTION; RACE DIFFERENCE;

ADOLESCENT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANTIDEPRESSIVE AGENTS; CHILD; CHILD, PRESCHOOL; DEPRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SURVEYS; HISPANIC AMERICANS; HUMANS; LONGITUDINAL STUDIES; MALE; UNITED STATES;

EID: 77952629739     PISSN: 10775587     EISSN: 15526801     Source Type: Journal    
DOI: 10.1177/1077558709350884     Document Type: Article

References (41)

1. Aday, L.A., & Andersen, R. (1975). Development of indices of access to medical care. Ann Arbor, MI: Health Administration Press.
2. Aday, L.A., Flemming, G.V., & Andersen, R. (1984). Access to medical care in the U.S.: Who has it, who doesng't. Chicago: Pluribus.
3. Ai, C., & Norton, E. (2003). Interaction terms in logit and probit models. Economic Letters, 80, 123-129.
4. American Academy of Child and Adolescent Psychiatry. (1998). Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. Journal of the American Academy of Child & Adolescent Psychiatry, 37 (Suppl.), 63S-83S.
5. Andersen, R.M. (1968). Behavioral model of familiesg' use of health services. Chicago: Center for Health Administration Studies, University of Chicago.
6. Andersen, R.M. (1995). Revisiting the behavioral model and access to medical care: Does it matter? Journal of Health and Social Behavior, 36, 1-10.
7. Andersen, R.M., & Newman, J.F. (1973). Societal and individual determinants of medical care utilization in the United States. Milbank Memorial Fund Quarterly, 51, 95-124.
8. Bird, H.R., Andrews, H., Schwab-Stone, M., Goodman, S., Dulcan, M., Richters, J., et al. (1996). Global measures of impairment for epidemiologic and clinical use with children and adolescents. International Journal of Methods in Psychiatric Research, 6, 295-307.
9. Bird, H.R., Shaffer, D., Fisher, P., Gould, M., Staghezza, B., Chen, J.Y., et al. (1993). The Columbia Impairment Scale (CIS): Pilot findings on a measure of global impairment for children and adolescents. International Journal of Psychiatric Research, 3, 167-176.
10. Blinder, A. (1973). Wage discrimination: Reduced form and structural estimates. Journal of Human Resources, 8, 436-455.
11. Breslau, J., Aguilar-Gaxiola, S., Kendler, K.S., Su, M., Williams, D., & Kessler, R.C. (2006). Specifying race-ethnic differences in risk for psychiatric disorder in a USA national sample. Psychological Medicine, 36, 57.
12. Bridge, J.A., Iyengar, S., Salary, C., Barbe, R.P., Birmaher, B., Pincus, H.A., et al. (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment. Journal of the American Medical Association, 297, 1683-1696.
13. Bussing, R., Schoenberg, N., & Perwien, A. (1998). Knowledge and information about ADHD: Evidence of cultural differences among African-American and White parents. Social Science & Medicine, 46, 919-928.
14. Bussing, R., Schoenberg, N.E., Rogers, K.M., Zima, B.T., & Angus, S. (1998). Explanatory models of ADHD: Do they differ by ethnicity, child gender or treatment status? Journal of Emotional and Behavioral Disorders, 6, 233-241.
15. Chen, A.Y., & Chang, R.-K.R. (2002). Factors associated with prescription drug expenditures among children: An analysis of the medical expenditure panel survey. Pediatrics, 109, 728.
16. Chen, A.Y., & Escarce, J.J. (2008). Family structure and the treatment of childhood asthma. Medical Care, 46, 174-184.
17. Cohen, J. (1996). The Medical Expenditure Panel Survey: A national health information resource. Inquiry, 33, 373-389.
18. Cohen, J. (1997). Design and methods of the Medical Expenditures Panel Survey household component. Rockville, MD: Agency for Health Care Policy and Research.
19. Fairlie, R.W. (2005). An extension of the Blinder-Oaxaca decomposition technique to logit and probit models. Journal of Economic and Social Measurement, 30, 305-316.
20. Garland, E.J. (2004). Facing the evidence: Antidepressant treatment in children and adolescents. Canadian Medical Association Journal, 170, 489.
21. Glied, S., & Cuellar, A.E. (2003). Trends and issues in child and adolescent mental health. Health Affairs, 22 (5). 39.
22. Hahn, B.A. (1995). Childreng's health: Racial and ethnic differences in the use of prescription medications. Pediatrics, 95, 727.
23. Hammad, T.A., Laughren, T., & Racoosin, J. (2006). Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry, 63, 332-339.
24. Hudson, J.L., Miller, G.E., & Kirby, J.B. (2007). Explaining racial and ethnic differences in childreng's use of stimulant medications. Medical Care, 45, 1068-1075.
25. Hunkeler, E.M., Fireman, B., Lee, J., Diamond, R., Hamilton, J., He, C.X., et al. (2005). Trends in use of antidepressants, lithium, and anticonvulsants in Kaiser Permanente-insured youths, 1994-2003. Journal of Child and Adolescent Psychopharmacology, 15, 26-37.
26. Millman, M. (1993). Access to health care in America. Washington, DC: National Academies Press.
27. Moeller, J., Stagnitti, M., Horan, E., Ward, P., Kieffer, N., & Hock, E. (2001). Outpatient prescription drugs: Data collection and editing in the 1996 Medical Expenditure Panel Survey (Pub. No. 01-0002). Rockville, MD: Agency for Healthcare Research and Quality.
28. Oaxaca, R.L. (1973). Male-female wage differentials in urban labor markets. International Economic Review, 14, 693-709.
29. Olfson, M., Shaffer, D., Marcus, S.C., & Greenberg, T. (2003). Relationship between antidepressant medication treatment and suicide in adolescents. Archives of General Psychiatry, 60, 978-982.
30. Raghavan, R., Zima, B.T., Andersen, R.M., Leibowitz, A.A., Schuster, M.A., & Landsverk, J. (2005). Psychotropic medication use in a national probability sample of children in the child welfare system. Journal of Child and Adolescent Psychopharmacology, 15, 97-106.
31. Riolo, S.A., Nguyen, T.A., Greden, J.F., & King, C.A. (2005). Prevalence of depression by race/ethnicity: Findings from the National Health and Nutrition Examination Survey III. American Journal of Public Health, 95, 998-1000.
32. Rowland, A.S., Umbach, D.M., Stallone, L., Naftel, A.J., Bohlig, E.M., & Sandler, D.P. (2002). Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina. American Journal of Public Health, 92, 231-234.
33. Rust, K.F., & Rao, J.N.K. (1996). Variance estimation for complex surveys using replication techniques. Statistical Methods in Medical Research, 5, 283-310.
34. Ryan, N.D. (2005). Treatment of depression in children and adolescents. Lancet, 366 (9489). 933-940.
35. Safer, D.J., Zito, J.M., & DosReis, S. (2003). Concomitant psychotropic medication for youths. American Journal of Psychiatry, 160, 438-449.
36. U.S. Food and Drug Administration. (2005). Relationship between psychotropic drugs and pediatric suicidality: Review and evaluation of clinical data. Retrieved September 24, 2009, from http://www.fda.gov/ohrms/dockets/ac/04/ briefing/2004-4065b1-10-TAB08-Hammads-Review.pdf
37. Wolter, K.M. (1985). Introduction to variance estimation. New York: Springer-Verlag.
38. Zito, J.M., Safer, D.J., DosReis, S., Gardner, J.F., Soeken, K., Boles, M., & Lynch, F. (2002). Rising prevalence of antidepressants among U.S. youths. Pediatrics, 109, 721-727.
39. Zito, J.M., Safer, D.J., DosReis, S., & Riddle, M.A. (1998). Racial disparity in psychotropic medications prescribed for youths with Medicaid insurance in Maryland. Journal of the American Academy of Child & Adolescent Psychiatry, 37, 179-184.
40. Zito, J.M., Safer, D.J., Zuckerman, I.H., Gardner, J.F., & Soeken, K. (2005). Effect of medicaid eligibility category on racial disparities in the use of psychotropic medications among youths. Psychiatric Services, 56, 157-163.
41. Zuvekas, S.H., & Fleishman, J.A. (2008). Self-rated mental health and racial/ethnic disparities in mental health service use. Medical Care, 46, 915-923.